Cadila Pharma launches esomeprazole tablets in India

July 11, 2020 0 By FM

Cadila Pharmaceuticals has announced the launch of esomeprazole tablets (Esiloc) for the treatment of hyperacidity and drug-induced gastritis.

The drug will be made available in 20 mg and 40 mg tablets, said the company.

Esomeprazole is a proton pump inhibitor (PPI), that acts on the luminal surface of gastric parietal cells, causing inhibition of acid secretion. 
Esomeprazole also showed higher rates of healing of erosive gastro-oesophageal reflux (GERD) and sustained resolution of heartburn in patients. GERD, if left untreated, can lead to conditions like peptic ulcer, chest pain, oesophagus cancer and other fatal conditions.